Sourcebio International PLC
LSE:SBI
Sourcebio International PLC
LSE:SBI
Price:
115 GBX
4.55%
Market Closed
Updated:
May 14, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
0.8
Current
0.8
Median
2.5
Industry
Higher
than median
Lower
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=0.8
Enterprise Value
/
85m
Revenue
103.2m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| UK |
|
Sourcebio International PLC
LSE:SBI
|
85.3m GBP | 0.8 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
92.4B EUR | 0.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
98.6B USD | 0.6 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
69.3B USD | 0.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17.6B USD | 1.7 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16.1B EUR | 1.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.4B USD | 2 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
12B EUR | 1.1 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.8B EUR | 1.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12B USD | 1.7 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.6 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
2.2
2-Years Forward
EV/S
2
3-Years Forward
EV/S
1.7
You don't have any saved screeners yet
